Aarti Asnani

Aarti Asnani

Harvard University

H-index: 22

North America-United States

About Aarti Asnani

Aarti Asnani, With an exceptional h-index of 22 and a recent h-index of 22 (since 2020), a distinguished researcher at Harvard University, specializes in the field of Cardio-oncology.

His recent articles reflect a diverse array of research interests and contributions to the field:

THE GLOBAL CARDIO-ONCOLOGY REGISTRY (G-COR) US PILOT STUDY: EARLY COHORT BREAST CANCER PATIENTS DEMOGRAPHICS AND EXERCISE HABITS

Renal biomarkers in heart failure: systematic review and meta-analysis

Assessing STEMI Outcomes in Patients With Cancer: A Call for Integrated Cardiovascular and Cancer Phenotyping

Inhibition of Cyp1a Protects Mice against Anthracycline Cardiomyopathy

Cardiomyocyte PGC-1α enables physiological adaptations to endurance exercise through suppression of GDF15 and cardiac atrophy

Atorvastatin for anthracycline-associated cardiac dysfunction: the STOP-CA randomized clinical trial

Abstract P3064: Cytotoxic T-cells Drive Doxorubicin Induced Cardiac Fibrosis And Systolic Dysfunction

Sustained alternate-day fasting potentiates doxorubicin cardiotoxicity

Aarti Asnani Information

University

Position

Beth Israel Deaconess Medical Center

Citations(all)

2577

Citations(since 2020)

1648

Cited By

1363

hIndex(all)

22

hIndex(since 2020)

22

i10Index(all)

36

i10Index(since 2020)

36

Email

University Profile Page

Google Scholar

Aarti Asnani Skills & Research Interests

Cardio-oncology

Top articles of Aarti Asnani

THE GLOBAL CARDIO-ONCOLOGY REGISTRY (G-COR) US PILOT STUDY: EARLY COHORT BREAST CANCER PATIENTS DEMOGRAPHICS AND EXERCISE HABITS

Journal of the American College of Cardiology

2024/4/2

Renal biomarkers in heart failure: systematic review and meta-analysis

2024/2/1

Assessing STEMI Outcomes in Patients With Cancer: A Call for Integrated Cardiovascular and Cancer Phenotyping

2024/1/9

Aarti Asnani
Aarti Asnani

H-Index: 13

Inhibition of Cyp1a Protects Mice against Anthracycline Cardiomyopathy

bioRxiv

2024

Cardiomyocyte PGC-1α enables physiological adaptations to endurance exercise through suppression of GDF15 and cardiac atrophy

bioRxiv

2024

Atorvastatin for anthracycline-associated cardiac dysfunction: the STOP-CA randomized clinical trial

JAMA

2023/8/8

Abstract P3064: Cytotoxic T-cells Drive Doxorubicin Induced Cardiac Fibrosis And Systolic Dysfunction

Circulation Research

2023/8/4

Kuljeet Kaur
Kuljeet Kaur

H-Index: 7

Aarti Asnani
Aarti Asnani

H-Index: 13

Sustained alternate-day fasting potentiates doxorubicin cardiotoxicity

Cell metabolism

2023/6/6

New Insights Into Cardiac Wasting in Patients With Cancer

2023/4/25

Aarti Asnani
Aarti Asnani

H-Index: 13

Efficacy and safety of catheter ablation for atrial fibrillation in patients with history of cancer

Cardio-Oncology

2023/4/5

Intermittent Fasting Potentiates Anthracycline Cardiotoxicity

Journal of Cardiac Failure

2023/4/1

CARDIOTOXICITY OF COMBINED PEGYLATED LIPOSOMAL DOXORUBICIN AND BEVACIZUMAB THERAPY

Journal of the American College of Cardiology

2023/3/7

Aarti Asnani
Aarti Asnani

H-Index: 13

CLINICAL FEATURES AND OUTCOMES OF CARDIAC INVOLVEMENT IN PATIENTS WITH CANCER TREATED WITH IMMUNE CHECKPOINT INHIBITORS

Journal of the American College of Cardiology

2023/3/7

The spatial ventricular gradient is an independent predictor of anthracycline-associated cardiotoxicity

JACC: Advances

2023/3/1

Gabriel Pajares Hurtado
Gabriel Pajares Hurtado

H-Index: 1

Aarti Asnani
Aarti Asnani

H-Index: 13

Apolipoprotein M attenuates anthracycline cardiotoxicity and lysosomal injury

Basic to Translational Science

2023/3/1

Prolactin inhibition in peripartum cardiomyopathy: systematic review and meta-analysis

2023/2/1

Priorities in Cardio-Oncology Basic and Translational Science: GCOS 2023 Symposium Proceedings: JACC: CardioOncology State-of-the-Art Review

2023/12/1

Pre-Existing Cardiovascular Disease Increases the Risk of Cardiovascular Adverse Events during Bruton Tyrosine Kinase Inhibitor Therapy

Blood

2023/11/28

Eunice Kim
Eunice Kim

H-Index: 13

Aarti Asnani
Aarti Asnani

H-Index: 13

Sex Differences in the Development of Anthracycline-Associated Heart Failure

Journal of Cardiac Failure

2023/11/10

Gabriel Pajares Hurtado
Gabriel Pajares Hurtado

H-Index: 1

Aarti Asnani
Aarti Asnani

H-Index: 13

Cardiomyocyte PGC-1α Prevents Cardiac Atrophy and Failure in Response to Endurance Exercise Training

Circulation

2023/11/7

See List of Professors in Aarti Asnani University(Harvard University)